Experienced in Esophageal Atresia Coloboma Talipes

Dr. Charles P. Vanderpool

Pediatric Gastroenterology | Gastroenterology
705 Riley Hospital Dr, Roc 4210, 
Indianapolis, IN 
Accepting New Patients
Experienced in Esophageal Atresia Coloboma Talipes
705 Riley Hospital Dr, Roc 4210, 
Indianapolis, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Vanderpool is a Pediatric Gastroenterologist and a Gastroenterologist in Indianapolis, Indiana. Dr. Vanderpool is rated as an Experienced provider by MediFind in the treatment of Esophageal Atresia Coloboma Talipes. His top areas of expertise are Short Bowel Syndrome, Atresia of Small Intestine, Gastroschisis, and Malnutrition. Dr. Vanderpool is currently accepting new patients.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Gastroenterology
Gastroenterology
Licenses
Pediatric Gastroenterology in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 8 Less Insurance Carriers -

Locations

705 Riley Hospital Dr, Roc 4210, Indianapolis, IN 46202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Drug, Device, Other
Study Phase: Phase 3
A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003
A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

20 Total Publications

Functional Infant Formula Additives.
Functional Infant Formula Additives.
Journal: NeoReviews
Published: February 28, 2025
Similar Doctors
Experienced in Esophageal Atresia Coloboma Talipes
Dr. John Wo
Gastroenterology
Experienced in Esophageal Atresia Coloboma Talipes
Dr. John Wo
Gastroenterology

University Medical Diagnostic Associates Inc

550 N University Blvd, 
Indianapolis, IN 
 (0.2 miles away)
217-274-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Wo is a Gastroenterologist in Indianapolis, Indiana. Dr. Wo is rated as a Distinguished provider by MediFind in the treatment of Esophageal Atresia Coloboma Talipes. His top areas of expertise are Gastroparesis, Painful Swallowing, Swallowing Difficulty, and Achalasia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vanderpool's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile